ID
45228
Description
Principal Investigator: MeSH: Major Depressive Disorder https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000020 Identification of genomic regions that confer susceptibility to or protection from major depressive disorder (MDD) via genomewide association. *Consent groups and participant set* - Psychiatric and Related Somatic Conditions (PRSC): 3741 (1821 cases, 1822 controls, 98 others)
Lien
Mots-clés
Versions (2)
- 2022-07-26 2022-07-26 - Martin Dugas
- 2022-10-12 2022-10-12 - Adrian Schulz
Détendeur de droits
Patrick F. Sullivan, University of North Carolina, Chapel Hill, NC, USA
Téléchargé le
12 oktober 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000020 Major Depression: Stage 1 Genomewide Association in Population-Based Samples
Eligibility Criteria
- StudyEvent: 44968_dbGaP phs000020 Major Depression: Stage 1 Genomewide Association in Population-Based Samples
- Eligibility Criteria
- The data table contains diagnostic phenotype data which provide the basis for diagnosis of major depressive disorder according to the Composite Interview Diagnostic Interview (CIDI): Depressive Disorder section (n=3 variables). Data has been collected from the Amsterdam Biographic Survey (ABV) for neuroticism (n=31 variables) and somatic complaints (n=18 variables), Beck Depression Invetory (BDI) for depression symptoms (n=14 variables), Beck Anxiety Inventory (BAI) for clinical anxiety (n=22 variables), Inventory of Depressive Symptoms (IDS) for psychometric properties (n=31 variables), NEO-FFI for neuroticism (n=13 variables), YASR Anxious Depression Survey from 1991, 1995, 1997, 2000, and 2002 (n=65 variables), and Spielberger Trait Anxiety Inventory (STAI, n=21 variables). Basic sociodemographic variables (n=7 variables), and family history of major depression (n=1 variable), and environmental factors (n=2 variables) are included.
- The data table includes the variable for the number of major depressive disorder episodes according to the Composite Interview Diagnostic Interview (CIDI): Depressive Disorder section.
- The data table contains a complete listing of subjects and consent group.
Similar models
Eligibility Criteria
- StudyEvent: 44968_dbGaP phs000020 Major Depression: Stage 1 Genomewide Association in Population-Based Samples
- Eligibility Criteria
- The data table contains diagnostic phenotype data which provide the basis for diagnosis of major depressive disorder according to the Composite Interview Diagnostic Interview (CIDI): Depressive Disorder section (n=3 variables). Data has been collected from the Amsterdam Biographic Survey (ABV) for neuroticism (n=31 variables) and somatic complaints (n=18 variables), Beck Depression Invetory (BDI) for depression symptoms (n=14 variables), Beck Anxiety Inventory (BAI) for clinical anxiety (n=22 variables), Inventory of Depressive Symptoms (IDS) for psychometric properties (n=31 variables), NEO-FFI for neuroticism (n=13 variables), YASR Anxious Depression Survey from 1991, 1995, 1997, 2000, and 2002 (n=65 variables), and Spielberger Trait Anxiety Inventory (STAI, n=21 variables). Basic sociodemographic variables (n=7 variables), and family history of major depression (n=1 variable), and environmental factors (n=2 variables) are included.
- The data table includes the variable for the number of major depressive disorder episodes according to the Composite Interview Diagnostic Interview (CIDI): Depressive Disorder section.
- The data table contains a complete listing of subjects and consent group.